Omnicell Inc. Stock
Price
Target price
€26.60
€26.60
-0.750%
-0.2
-0.750%
€39.55
13.08.25 / Frankfurt
WKN: 632313 / Symbol: OMCL / Name: Omnicell / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Omnicell Inc. Stock
The price for the Omnicell Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.200 (-0.750%).
With 11 Buy predictions and not the single Sell prediction the community is currently very high on Omnicell Inc..
With a target price of 39 € there is a positive potential of 46.62% for Omnicell Inc. compared to the current price of 26.6 €.
Pros and Cons of Omnicell Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omnicell Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Omnicell Inc. | -0.750% | 0.758% | 13.675% | -29.630% | -36.058% | -74.667% | -55.667% |
| Healthequity Inc. | -3.820% | -1.948% | -8.485% | 17.969% | -17.033% | 27.966% | 56.639% |
| Bruker Corp. | -1.560% | 8.003% | -22.051% | -48.244% | -47.926% | - | - |
| Integer Hldg | 2.200% | 3.333% | -8.824% | -12.264% | -26.772% | 31.915% | 60.345% |
Comments
Omnicell, Inc. (NASDAQ: OMCL) had its price target lowered by analysts at Piper Sandler from $57.00 to $55.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell, Inc. (NASDAQ: OMCL) had its price target raised by analysts at Wells Fargo & Company from $37.00 to $40.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell, Inc. (NASDAQ: OMCL) had its "overweight" rating re-affirmed by analysts at Piper Sandler.
Show more
Ratings data for OMCL provided by MarketBeat